BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36958800)

  • 1. Comparison between Dual-Energy CT and Quantitative Susceptibility Mapping in Assessing Brain Iron Deposition in Parkinson Disease.
    Chen Y; Ge M; Kang JJ; Ding YC; Chen YC; Jia ZZ
    AJNR Am J Neuroradiol; 2023 Apr; 44(4):410-416. PubMed ID: 36958800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.
    Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R
    Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility Mapping.
    Azuma M; Hirai T; Yamada K; Yamashita S; Ando Y; Tateishi M; Iryo Y; Yoneda T; Kitajima M; Wang Y; Yamashita Y
    AJNR Am J Neuroradiol; 2016 May; 37(5):782-8. PubMed ID: 26822728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemisphere, gender and age-related effects on iron deposition in deep gray matter revealed by quantitative susceptibility mapping.
    Gong NJ; Wong CS; Hui ES; Chan CC; Leung LM
    NMR Biomed; 2015 Oct; 28(10):1267-74. PubMed ID: 26313542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain MRI with Quantitative Susceptibility Mapping: Relationship to CT Attenuation Values.
    Oshima S; Fushimi Y; Okada T; Takakura K; Liu C; Yokota Y; Arakawa Y; Sawamoto N; Miyamoto S; Togashi K
    Radiology; 2020 Mar; 294(3):600-609. PubMed ID: 31909699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
    Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
    BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease.
    Murakami Y; Kakeda S; Watanabe K; Ueda I; Ogasawara A; Moriya J; Ide S; Futatsuya K; Sato T; Okada K; Uozumi T; Tsuji S; Liu T; Wang Y; Korogi Y
    AJNR Am J Neuroradiol; 2015 Jun; 36(6):1102-8. PubMed ID: 25767187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
    He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
    Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating iron deposition in gray matter nuclei of patients with unilateral middle cerebral artery stenosis using quantitative susceptibility mapping.
    Mao H; Dou W; Chen K; Wang X; Wang X; Guo Y; Zhang C
    Neuroimage Clin; 2022; 34():103021. PubMed ID: 35500369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Mild Cognitive Impairment in Parkinson's Disease by Magnetic Resonance Quantitative Susceptibility Mapping Combined Voxel-Wise and Radiomic Analysis.
    Zhao Y; Qu H; Wang W; Liu J; Pan Y; Li Z; Xu G; Hu C
    Eur Neurol; 2022; 85(4):280-290. PubMed ID: 35313305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping.
    Xu M; Guo Y; Cheng J; Xue K; Yang M; Song X; Feng Y; Cheng J
    Neuroimage Clin; 2021; 31():102736. PubMed ID: 34186296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
    Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
    Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of iron content in idiopathic rapid eye movement sleep behavior disorder.
    Sun J; Lai Z; Ma J; Gao L; Chen M; Chen J; Fang J; Fan Y; Bao Y; Zhang D; Chan P; Yang Q; Ye C; Wu T; Ma T
    Mov Disord; 2020 Mar; 35(3):478-485. PubMed ID: 31846123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
    Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
    Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of cerebral iron content in patients with Parkinson's disease by the susceptibility-weighted MRI.
    Wu SF; Zhu ZF; Kong Y; Zhang HP; Zhou GQ; Jiang QT; Meng XP
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2605-8. PubMed ID: 25317792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative evaluation of brain iron accumulation in different stages of Parkinson's disease.
    Li KR; Avecillas-Chasin J; Nguyen TD; Gillen KM; Dimov A; Chang E; Skudin C; Kopell BH; Wang Y; Shtilbans A
    J Neuroimaging; 2022 Mar; 32(2):363-371. PubMed ID: 34904328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Provides Potential Biomarkers for Early-Stage Parkinson's Disease.
    Rong Y; Xu Z; Zhu Y; Zhang X; Lai L; Sun S; Gao M; Guo P; Zhang G; Geng Y; Ma X; Wu S; Yang L; Shen Z; Guan J
    ACS Chem Neurosci; 2022 Sep; 13(18):2699-2708. PubMed ID: 36047877
    [No Abstract]   [Full Text] [Related]  

  • 18. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping.
    Bilgic B; Pfefferbaum A; Rohlfing T; Sullivan EV; Adalsteinsson E
    Neuroimage; 2012 Feb; 59(3):2625-35. PubMed ID: 21925274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effect of Iron and Myelin on Susceptibility MRI in the Substantia Nigra.
    Lee H; Cho H; Lee MJ; Kim TH; Roh J; Lee JH
    Radiology; 2021 Dec; 301(3):682-691. PubMed ID: 34609198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Susceptibility Mapping of Brain Iron Relating to Cognitive Impairment in Hypertension.
    Qin Z; Wu W; Liu D; Zheng C; Kang J; Zhou H; Meng X; Haacke EM; Wang L
    J Magn Reson Imaging; 2022 Aug; 56(2):508-515. PubMed ID: 34989062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.